<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Nafarelin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Nafarelin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Nafarelin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Nafarelin</b>, sold under the brand name <b>Synarel</b> among others, is a gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in the treatment of endometriosis and early puberty.<span class="mw-ref" id="cite_ref-pmid2140979_1-1"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-8"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is also used to treat uterine fibroids, to control ovarian stimulation in <i>in vitro</i> fertilization (IVF), and as part of transgender hormone therapy.<span class="mw-ref" id="cite_ref-pmid10900582_3-0"><a href="#cite_note-pmid10900582-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Mutschler2001_4-0"><a href="#cite_note-Mutschler2001-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-pmid27241976_5-0"><a href="#cite_note-pmid27241976-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-pmid23385274_6-0"><a href="#cite_note-pmid23385274-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> The medication is used as a nasal spray two to three times per day.<span class="mw-ref" id="cite_ref-pmid2140979_1-2"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-9"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid22028996_7-0"><a href="#cite_note-pmid22028996-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Nafarelin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Nafarelin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Nafarelin.svg.png" data-file-width="512" data-file-height="315" data-file-type="drawing" height="154" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Synarel, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Nafareline; Nafarelin acetate; RS-94991; RS-94991-298; [6-<small>D</small>-(2-naphthyl)alanine]-GnRH</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/synarel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/synarel.html'" tppabs="https://www.drugs.com/monograph/synarel.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a601082.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a601082.html'" tppabs="https://medlineplus.gov/druginfo/meds/a601082.html" class="external text external">a601082</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>X</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>Nasal spray<span class="mw-ref" id="cite_ref-pmid2140979_1-0"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-0"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>GnRH analogue; GnRH agonist; Antigonadotropin</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>H01CA02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=H01CA02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=H01CA02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=H01CA02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td><abbr>IN</abbr>: 2.8% (1.2–5.6%)<span class="mw-ref" id="cite_ref-SynarelLabel_2-1"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>80%<span class="mw-ref" id="cite_ref-SynarelLabel_2-2"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Peptidases (not <abbr>CYP450</abbr>)<span class="mw-ref" id="cite_ref-SynarelLabel_2-3"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td><abbr>IN</abbr>: 2.5–3.0 hours<span class="mw-ref" id="cite_ref-SynarelLabel_2-4"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><br><span style="font-family:sans-serif;font-size:98%;color:black;background-color:transparent;;"><abbr>SC</abbr>: 86 hours (metabolites)<span class="mw-ref" id="cite_ref-SynarelLabel_2-5"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine: 44–55%<span class="mw-ref" id="cite_ref-SynarelLabel_2-6"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><br>Feces: 19–44%<span class="mw-ref" id="cite_ref-SynarelLabel_2-7"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(2<i>R</i>)-<i>N</i>-[(2<i>R</i>)-5-carbamimidamido-1-[(2<i>S</i>)-2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopentan-2-yl]-2-[(2<i>R</i>)-2-[(2<i>R</i>)-2-[(2<i>R</i>)-3-hydroxy-2-[(2<i>S</i>)-2-[(2<i>S</i>)-3-(1<i>H</i>-imidazol-4-yl)-2-{[(2<i>R</i>)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1<i>H</i>-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(naphthalen-2-yl)propanamido]-4-methylpentanamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76932-56-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76932-56-4'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=76932-56-4" class="external text external">76932-56-4</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup> <br>76932-60-0 (acetate)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/25077649  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/25077649'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/25077649" class="external text external">25077649</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3902  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3902'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3902" class="external text external">3902</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00666  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00666'" tppabs="https://www.drugbank.ca/drugs/DB00666" class="external text external">DB00666</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.10482014.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.10482014.html'" tppabs="http://www.chemspider.com/Chemical-Structure.10482014.html" class="external text external">10482014</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1X0094V6JV  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1X0094V6JV'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=1X0094V6JV" class="external text external">1X0094V6JV</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08241  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08241'" tppabs="https://www.kegg.jp/entry/D08241" class="external text external">D08241</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7445  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7445'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7445" class="external text external">CHEBI:7445</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201309  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201309'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1201309" class="external text external">ChEMBL1201309</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.212.186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.212.186'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.212.186" class="external text external">100.212.186</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>66</sub><span>H</span><sub>83</sub><span>N</span><sub>17</sub><span>O</span><sub>13</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">1<span style="margin-left:.25em;">322</span>.496</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29C%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28CCCNC%28%3DN%29N%29C%28%3DO%29N1CCC%5BC%40H%5D1C%28%3DO%29NCC%28%3DO%29N%29NC%28%3DO%29%5BC%40%40H%5D%28CC2%3DCC3%3DCC%3DCC%3DC3C%3DC2%29NC%28%3DO%29%5BC%40H%5D%28CC4%3DCC%3DC%28C%3DC4%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC5%3DCNC6%3DCC%3DCC%3DC65%29NC%28%3DO%29%5BC%40H%5D%28CC7%3DCNC%3DN7%29NC%28%3DO%29%5BC%40%40H%5D8CCC%28%3DO%29N8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29C%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28CCCNC%28%3DN%29N%29C%28%3DO%29N1CCC%5BC%40H%5D1C%28%3DO%29NCC%28%3DO%29N%29NC%28%3DO%29%5BC%40%40H%5D%28CC2%3DCC3%3DCC%3DCC%3DC3C%3DC2%29NC%28%3DO%29%5BC%40H%5D%28CC4%3DCC%3DC%28C%3DC4%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC5%3DCNC6%3DCC%3DCC%3DC65%29NC%28%3DO%29%5BC%40H%5D%28CC7%3DCNC%3DN7%29NC%28%3DO%29%5BC%40%40H%5D8CCC%28%3DO%29N8'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%28C%29C%5BC%40%40H%5D%28C%28%3DO%29N%5BC%40%40H%5D%28CCCNC%28%3DN%29N%29C%28%3DO%29N1CCC%5BC%40H%5D1C%28%3DO%29NCC%28%3DO%29N%29NC%28%3DO%29%5BC%40%40H%5D%28CC2%3DCC3%3DCC%3DCC%3DC3C%3DC2%29NC%28%3DO%29%5BC%40H%5D%28CC4%3DCC%3DC%28C%3DC4%29O%29NC%28%3DO%29%5BC%40H%5D%28CO%29NC%28%3DO%29%5BC%40H%5D%28CC5%3DCNC6%3DCC%3DCC%3DC65%29NC%28%3DO%29%5BC%40H%5D%28CC7%3DCNC%3DN7%29NC%28%3DO%29%5BC%40%40H%5D8CCC%28%3DO%29N8" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CNC=N7)NC(=O)[C@@H]8CCC(=O)N8</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C66H83N17O13/c1-36(2)25-48(58(89)76-47(13-7-23-71-66(68)69)65(96)83-24-8-14-54(83)64(95)73-33-55(67)86)77-60(91)50(28-38-15-18-39-9-3-4-10-40(39)26-38)78-59(90)49(27-37-16-19-43(85)20-17-37)79-63(94)53(34-84)82-61(92)51(29-41-31-72-45-12-6-5-11-44(41)45)80-62(93)52(30-42-32-70-35-74-42)81-57(88)46-21-22-56(87)75-46/h3-6,9-12,15-20,26,31-32,35-36,46-54,72,84-85H,7-8,13-14,21-25,27-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,90)(H,79,94)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71)/t46-,47-,48-,49-,50+,51-,52-,53-,54-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:RWHUEXWOYVBUCI-ITQXDASVSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462258124&page2=Nafarelin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462258124&page2=Nafarelin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462258124&page2=Nafarelin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Side effects of nafarelin are related to sex hormone deprivation and include symptoms of low testosterone levels and low estrogen levels such as hot flashes, sexual dysfunction, vaginal atrophy, and osteoporosis.<span class="mw-ref" id="cite_ref-SynarelLabel_2-10"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Nafarelin is a gonadotropin-releasing hormone agonist (GnRH agonist) and works by preventing the production of sex hormones by the gonads.<span class="mw-ref" id="cite_ref-pmid2140979_1-3"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-11"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It can lower sex hormone levels by 95% in both sexes.<span class="mw-ref" id="cite_ref-pmid2140979_1-4"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-12"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Nafarelin is a peptide and an analogue of <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr></a>.<span class="mw-ref" id="cite_ref-Srivastava2017_8-0"><a href="#cite_note-Srivastava2017-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


<p>Nafarelin was introduced for medical use in 1990.<span class="mw-ref" id="cite_ref-Drugs@FDA_9-0"><a href="#cite_note-Drugs@FDA-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid2140979_1-5"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid1984190_10-0"><a href="#cite_note-pmid1984190-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It is available widely throughout the world, including in North America, Europe, and elsewhere throughout the world.<span class="mw-ref" id="cite_ref-Drugs.com_11-0"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_12-0"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The medication is one of only two medically used GnRH analogues that are available as nasal sprays, the other being buserelin.<span class="mw-ref" id="cite_ref-Önerci2013_13-0"><a href="#cite_note-Önerci2013-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Nafarelin is approved and used in the treatment of endometriosis and precocious puberty.<span class="mw-ref" id="cite_ref-SynarelLabel_2-13"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid2140979_1-6"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is also used in the treatment of uterine fibroids.<span class="mw-ref" id="cite_ref-pmid10900582_3-1"><a href="#cite_note-pmid10900582-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid2533618_14-0"><a href="#cite_note-pmid2533618-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The medication is used to control ovarian stimulation in <i>in vitro</i> fertilization (IVF).<span class="mw-ref" id="cite_ref-Mutschler2001_4-1"><a href="#cite_note-Mutschler2001-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Nafarelin is used as a puberty blocker in transgender youth and to suppress <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a> levels in transgender women.<span class="mw-ref" id="cite_ref-LeePerl2018_16-0"><a href="#cite_note-LeePerl2018-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-pmid27241976_5-1"><a href="#cite_note-pmid27241976-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-pmid24972421_17-0"><a href="#cite_note-pmid24972421-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-pmid23385274_6-1"><a href="#cite_note-pmid23385274-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Nakatsuka2014_18-0"><a href="#cite_note-Nakatsuka2014-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Nafarelin can also be used to treat hirsutism and polycystic ovary syndrome by lowering gonadotropin and androgen levels.<span class="mw-ref" id="cite_ref-pmid2140979_1-7"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid2533618_14-1"><a href="#cite_note-pmid2533618-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-pmid2969835_19-0"><a href="#cite_note-pmid2969835-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It is effective in the treatment of benign prostatic hyperplasia.<span class="mw-ref" id="cite_ref-pmid2140979_1-8"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Dosages">Dosages</h3></summary>
    
<p>Nafarelin is used to treat precocious puberty at a dosage of 1,600 to 1,800<span>&nbsp;</span>μg per day.<span class="mw-ref" id="cite_ref-SynarelLabel_2-14"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The 1,600<span>&nbsp;</span>μg/day dosage is achieved by two sprays (400<span>&nbsp;</span>μg total) into each nostril in the morning (four sprays, 800<span>&nbsp;</span>μg total) and two sprays (400<span>&nbsp;</span>μg total) into each nostril in the evening (four sprays, 800<span>&nbsp;</span>μg total).<span class="mw-ref" id="cite_ref-SynarelLabel_2-15"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> If 1,600<span>&nbsp;</span>mg/day is insufficient for adequate pubertal suppression, the 1,800<span>&nbsp;</span>μg/day dosage can be used instead. This is achieved by three sprays (600<span>&nbsp;</span>μg total) into alternating nostrils three times per day (nine sprays per day total).<span class="mw-ref" id="cite_ref-SynarelLabel_2-16"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> When administering the sprays, the head should be tilted back slightly and 30<span>&nbsp;</span>seconds should elapse between each spray.<span class="mw-ref" id="cite_ref-SynarelLabel_2-17"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> A bottle of nafarelin nasal spray (brand name Synarel) lasts for about 7<span>&nbsp;</span>days at a dosage of 1,600<span>&nbsp;</span>μg/day.<span class="mw-ref" id="cite_ref-SynarelLabel_2-18"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Nafarelin is used to treat endometriosis at lower dosages of 400 to 800<span>&nbsp;</span>μg per day.<span class="mw-ref" id="cite_ref-SynarelLabel_2-19"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> This is achieved by one or two sprays (200 or 400<span>&nbsp;</span>μg total) into alternating nostrils once in the morning and once in the evening (two to four sprays per day total).<span class="mw-ref" id="cite_ref-SynarelLabel_2-20"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> A bottle of nafarelin nasal spray (brand name Synarel) lasts for about 30<span>&nbsp;</span>days at a dosage of 400<span>&nbsp;</span>μg/day.<span class="mw-ref" id="cite_ref-SynarelLabel_2-21"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Nafarelin is available in the form of a 0.2% nasal spray for use one, two, or three times per day.<span class="mw-ref" id="cite_ref-LemkeWilliams2012_20-0"><a href="#cite_note-LemkeWilliams2012-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-22"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid2140979_1-9"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Each bottle of nafarelin nasal spray (brand name Synarel) contains about 60<span>&nbsp;</span>sprays delivering approximately 200<span>&nbsp;</span>μg nafarelin in 100<span>&nbsp;</span>μL solution per actuation.<span class="mw-ref" id="cite_ref-SynarelLabel_2-23"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Nafarelin is not available for use by any other routes than intranasal administration.<span class="mw-ref" id="cite_ref-FalconeHurd2017_21-0"><a href="#cite_note-FalconeHurd2017-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>Side effects of nafarelin are related to sex hormone deficiency and include hot flashes, vaginal dryness, headaches, mood changes, and sexual dysfunction. Nafarelin causes erectile dysfunction in more than half of men with benign prostatic hyperplasia treated with it.<span class="mw-ref" id="cite_ref-MunarrizTraish2009_22-0"><a href="#cite_note-MunarrizTraish2009-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Some people may experience acne, muscle pain, reduced breast size, and nasal irritation. These side effects are reversible and should resolve after stopping the medication.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> There is a case report of severe hyperkalemia during nafarelin therapy in a woman with uterine fibroids.<span class="mw-ref" id="cite_ref-pmid8569395_24-0"><a href="#cite_note-pmid8569395-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> The mechanism is unknown.<span class="mw-ref" id="cite_ref-pmid8569395_24-1"><a href="#cite_note-pmid8569395-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Nafarelin is a GnRH agonist, or an agonist of the GnRH receptor, the biological target of <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/GnRH" title="GnRH" class="mw-redirect">GnRH</a>.<span class="mw-ref" id="cite_ref-pmid2140979_1-10"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-24"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It works by continuously activating the GnRH receptor, which results in profound desensitization of the receptor such that it becomes non-functional.<span class="mw-ref" id="cite_ref-pmid2140979_1-11"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-25"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> As a result, nafarelin suppresses the GnRH-induced secretion of the gonadotropins, <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a> and follicle-stimulating hormone, from the pituitary gland.<span class="mw-ref" id="cite_ref-pmid2140979_1-12"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-26"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> This, in turn, results in profound suppression of gonadal sex hormone production, as well as reversible suppression of fertility.<span class="mw-ref" id="cite_ref-pmid2140979_1-13"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-27"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>The bioavailability of nafarelin with intranasal administration is 2.8% on average, with a range of 1.2 to 5.6%.<span class="mw-ref" id="cite_ref-SynarelLabel_2-28"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The plasma protein binding of nafarelin is 80%.<span class="mw-ref" id="cite_ref-SynarelLabel_2-29"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is metabolized primarily by peptidases and not by cytochrome P450 enzymes.<span class="mw-ref" id="cite_ref-SynarelLabel_2-30"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The elimination half-life of nafarelin is 2.5 to 3.0<span>&nbsp;</span>hours by intranasal administration, whereas the half-life of nafarelin and its metabolites by subcutaneous injection is 85.5<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-SynarelLabel_2-31"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Nafarelin is eliminated 44 to 55% in urine and 18.5 to 44.2% in feces.<span class="mw-ref" id="cite_ref-SynarelLabel_2-32"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Nafarelin is a GnRH analogue, or a synthetic analogue of GnRH.<span class="mw-ref" id="cite_ref-pmid2140979_1-14"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-SynarelLabel_2-33"><a href="#cite_note-SynarelLabel-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-FalconeHurd2017_21-1"><a href="#cite_note-FalconeHurd2017-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> It is a decapeptide and is also known as [6-<small>D</small>-(2-naphthyl)alanine]-GnRH.<span class="mw-ref" id="cite_ref-FalconeHurd2017_21-2"><a href="#cite_note-FalconeHurd2017-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-pmid8477775_25-0"><a href="#cite_note-pmid8477775-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Nafarelin is marketed for medical use in both its free base (nafarelin) and acetate salt (nafarelin acetate) forms.<span class="mw-ref" id="cite_ref-IndexNominum2000_12-1"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Nafarelin was introduced for medical use in 1990.<span class="mw-ref" id="cite_ref-Drugs@FDA_9-1"><a href="#cite_note-Drugs@FDA-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid2140979_1-15"><a href="#cite_note-pmid2140979-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-pmid1984190_10-1"><a href="#cite_note-pmid1984190-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Nafarelin</i> is the generic name of the drug and its <abbr>INN</abbr> and <abbr>BAN</abbr>, while <i>nafaréline</i> is its <abbr>DCF</abbr> and <i>nafarelin acetate</i> is its <abbr>USAN</abbr>, <abbr>BANM</abbr>, and <abbr>JAN</abbr>.<span class="mw-ref" id="cite_ref-Elks2014_26-0"><a href="#cite_note-Elks2014-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_12-2"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_27-0"><a href="#cite_note-MortonHall2012-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_11-1"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is also known by its former developmental code name <i>RS-94991</i> or <i>RS-94991-298</i>.<span class="mw-ref" id="cite_ref-Elks2014_26-1"><a href="#cite_note-Elks2014-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_12-3"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_27-1"><a href="#cite_note-MortonHall2012-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_11-2"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>The major brand names of nafarelin are Synarel and Synarela.<span class="mw-ref" id="cite_ref-IndexNominum2000_12-4"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_11-3"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It has also been marketed under a number of other brand names including Synrelin, Synrelina, Nafarelil 0.2%, and Nasanyl 0.2%.<span class="mw-ref" id="cite_ref-IndexNominum2000_12-5"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_11-4"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    
<p>Nafarelin is available widely throughout the world, including in the United States, Canada, the United Kingdom, Ireland, other European countries, Australia, Israel, Argentina, Brazil, Mexico, and Japan.<span class="mw-ref" id="cite_ref-IndexNominum2000_12-6"><a href="#cite_note-IndexNominum2000-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_11-5"><a href="#cite_note-Drugs.com-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Gonadotropin-releasing hormone receptor § Agonists</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-pmid2140979-1"> <span id="mw-reference-text-cite_note-pmid2140979-1" class="mw-reference-text"><cite id="CITEREFChrispGoa1990" class="citation journal cs1">Chrisp P, Goa KL (April 1990). "Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions". <i>Drugs</i>. <b>39</b> (4): 523–51. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199039040-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199039040-00005'" tppabs="https://doi.org/10.2165%2F00003495-199039040-00005" class="external text external">10.2165/00003495-199039040-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2140979  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2140979'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2140979" class="external text external">2140979</a>.</cite></span></li><li id="cite_note-SynarelLabel-2"> <span id="mw-reference-text-cite_note-SynarelLabel-2" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019886s033s035lbl.pdf</a></span></li><li id="cite_note-pmid10900582-3"> <span id="mw-reference-text-cite_note-pmid10900582-3" class="mw-reference-text"><cite id="CITEREFMinaguchiWongSnabes2000" class="citation journal cs1">Minaguchi H, Wong JM, Snabes MC (June 2000). "Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature". <i>J Reprod Med</i>. <b>45</b> (6): 481–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10900582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10900582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10900582" class="external text external">10900582</a>.</cite></span></li><li id="cite_note-Mutschler2001-4"> <span id="mw-reference-text-cite_note-Mutschler2001-4" class="mw-reference-text"><cite id="CITEREFMutschlerSchäfer-Korting2001" class="citation book cs1">Mutschler, Ernst; Schäfer-Korting, Monika (2001). <i>Arzneimittelwirkungen</i> (in German) (8 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. pp.<span>&nbsp;</span>372–3. ISBN<span>&nbsp;</span><bdi>3-8047-1763-2</bdi>.</cite></span></li><li id="cite_note-pmid27241976-5"> <span id="mw-reference-text-cite_note-pmid27241976-5" class="mw-reference-text"><cite id="CITEREFOlshanEimickeBelfort2016" class="citation journal cs1">Olshan J, Eimicke T, Belfort E (June 2016). "Gender Incongruity in Children With and Without Disorders of Sexual Differentiation". <i>Endocrinol. Metab. Clin. North Am</i>. <b>45</b> (2): 463–82. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ecl.2016.02.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ecl.2016.02.001'" tppabs="https://doi.org/10.1016%2Fj.ecl.2016.02.001" class="external text external">10.1016/j.ecl.2016.02.001</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27241976  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27241976'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27241976" class="external text external">27241976</a>.</cite></span></li><li id="cite_note-pmid23385274-6"> <span id="mw-reference-text-cite_note-pmid23385274-6" class="mw-reference-text"><cite id="CITEREFSpack2013" class="citation journal cs1">Spack NP (February 2013). "Management of transgenderism". <i>JAMA</i>. <b>309</b> (5): 478–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.2012.165234  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.2012.165234'" tppabs="https://doi.org/10.1001%2Fjama.2012.165234" class="external text external">10.1001/jama.2012.165234</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23385274  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23385274'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23385274" class="external text external">23385274</a>.</cite></span></li><li id="cite_note-pmid22028996-7"> <span id="mw-reference-text-cite_note-pmid22028996-7" class="mw-reference-text"><cite id="CITEREFMagon2011" class="citation journal cs1">Magon N (October 2011). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774" class="external text external">"Gonadotropin releasing hormone agonists: Expanding vistas"</a>. <i>Indian J Endocrinol Metab</i>. <b>15</b> (4): 261–7. doi:<a href="javascript:if(confirm('https://doi.org/10.4103%2F2230-8210.85575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4103%2F2230-8210.85575'" tppabs="https://doi.org/10.4103%2F2230-8210.85575" class="external text external">10.4103/2230-8210.85575</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193774" class="external text external">3193774</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22028996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22028996'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22028996" class="external text external">22028996</a>.</cite></span></li><li id="cite_note-Srivastava2017-8"> <span id="mw-reference-text-cite_note-Srivastava2017-8" class="mw-reference-text"><cite id="CITEREFVed_Srivastava2017" class="citation book cs1">Ved Srivastava (26 June 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=sbcpDwAAQBAJ&pg=PA182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=sbcpDwAAQBAJ&pg=PA182'" tppabs="https://books.google.com/books?id=sbcpDwAAQBAJ&pg=PA182" class="external text external"><i>Peptide-based Drug Discovery: Challenges and New Therapeutics</i></a>. Royal Society of Chemistry. pp.<span>&nbsp;</span>182–. ISBN<span>&nbsp;</span><bdi>978-1-78262-732-6</bdi>.</cite></span></li><li id="cite_note-Drugs@FDA-9"> <span id="mw-reference-text-cite_note-Drugs@FDA-9" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886" class="external free external">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&amp;ApplNo=019886</a></span></li><li id="cite_note-pmid1984190-10"> <span id="mw-reference-text-cite_note-pmid1984190-10" class="mw-reference-text"><cite id="CITEREFConnCrowley1991" class="citation journal cs1">Conn PM, Crowley WF (January 1991). "Gonadotropin-releasing hormone and its analogues". <i>N. Engl. J. Med</i>. <b>324</b> (2): 93–103. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM199101103240205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM199101103240205'" tppabs="https://doi.org/10.1056%2FNEJM199101103240205" class="external text external">10.1056/NEJM199101103240205</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1984190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1984190'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1984190" class="external text external">1984190</a>.</cite></span></li><li id="cite_note-Drugs.com-11"> <span id="mw-reference-text-cite_note-Drugs.com-11" class="mw-reference-text"><a href="javascript:if(confirm('https://www.drugs.com/international/nafarelin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/nafarelin.html'" tppabs="https://www.drugs.com/international/nafarelin.html" class="external free external">https://www.drugs.com/international/nafarelin.html</a></span></li><li id="cite_note-IndexNominum2000-12"> <span id="mw-reference-text-cite_note-IndexNominum2000-12" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA712  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA712'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA712" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.<span>&nbsp;</span>712–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-Önerci2013-13"> <span id="mw-reference-text-cite_note-Önerci2013-13" class="mw-reference-text"><cite id="CITEREFT._Metin_Önerci2013" class="citation book cs1">T. Metin Önerci (17 August 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=qfu8BAAAQBAJ&pg=PA208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=qfu8BAAAQBAJ&pg=PA208'" tppabs="https://books.google.com/books?id=qfu8BAAAQBAJ&pg=PA208" class="external text external"><i>Nasal Physiology and Pathophysiology of Nasal Disorders</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>208–. ISBN<span>&nbsp;</span><bdi>978-3-642-37250-6</bdi>.</cite></span></li><li id="cite_note-pmid2533618-14"> <span id="mw-reference-text-cite_note-pmid2533618-14" class="mw-reference-text"><cite id="CITEREFMonroeAndreyko1989" class="citation journal cs1">Monroe SE, Andreyko J (December 1989). "Treatment of uterine leiomyomas and hirsutism with nafarelin". <i>J Reprod Med</i>. <b>34</b> (12 Suppl): 1029–33. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2533618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2533618'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2533618" class="external text external">2533618</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFWuttkeJarryFelederMoguilevsky1996" class="citation journal cs1">Wuttke, W; Jarry, H; Feleder, C; Moguilevsky, J; Leonhardt, S; Seong, J. Y.; Kim, K (1996). <a href="javascript:if(confirm('http://www.ane.pl/linkout.php?vol=56&no=3&fpp=707  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ane.pl/linkout.php?vol=56&no=3&fpp=707'" tppabs="http://www.ane.pl/linkout.php?vol=56&no=3&fpp=707" class="external text external">"The neurochemistry of the GnRH pulse generator"</a>. <i>Acta neurobiologiae experimentalis</i>. <b>56</b> (3): 707–13. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8917899  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8917899'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8917899" class="external text external">8917899</a>.</cite></span></li><li id="cite_note-LeePerl2018-16"> <span id="mw-reference-text-cite_note-LeePerl2018-16" class="mw-reference-text"><cite id="CITEREFLeePerlRosenthal2018" class="citation journal cs1">Lee, Janet Y.; Perl, Liat; Rosenthal, Stephen M. (2018). "Care of Gender Nonconforming/Transgender Youth". <i>Pediatric Endocrinology</i>: 813–823. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-3-319-73782-9_36  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-3-319-73782-9_36'" tppabs="https://doi.org/10.1007%2F978-3-319-73782-9_36" class="external text external">10.1007/978-3-319-73782-9_36</a>.</cite></span></li><li id="cite_note-pmid24972421-17"> <span id="mw-reference-text-cite_note-pmid24972421-17" class="mw-reference-text"><cite id="CITEREFOlsonGarofalo2014" class="citation journal cs1">Olson J, Garofalo R (June 2014). "The peripubertal gender-dysphoric child: puberty suppression and treatment paradigms". <i>Pediatr Ann</i>. <b>43</b> (6): e132–7. doi:<a href="javascript:if(confirm('https://doi.org/10.3928%2F00904481-20140522-08  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3928%2F00904481-20140522-08'" tppabs="https://doi.org/10.3928%2F00904481-20140522-08" class="external text external">10.3928/00904481-20140522-08</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24972421  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24972421'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24972421" class="external text external">24972421</a>.</cite></span></li><li id="cite_note-Nakatsuka2014-18"> <span id="mw-reference-text-cite_note-Nakatsuka2014-18" class="mw-reference-text"><cite id="CITEREFNakatsuka2014" class="citation journal cs1">Nakatsuka, Mikiya (2014). "Endocrine treatment of transsexuals: assessment of cardiovascular risk factors". <i>Expert Review of Endocrinology &amp; Metabolism</i>. <b>5</b> (3): 319–322. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2Feem.10.18  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2Feem.10.18'" tppabs="https://doi.org/10.1586%2Feem.10.18" class="external text external">10.1586/eem.10.18</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1744-6651  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1744-6651'" tppabs="https://www.worldcat.org/issn/1744-6651" class="external text external">1744-6651</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30861686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30861686'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30861686" class="external text external">30861686</a>.</cite></span></li><li id="cite_note-pmid2969835-19"> <span id="mw-reference-text-cite_note-pmid2969835-19" class="mw-reference-text"><cite id="CITEREFShaw1988" class="citation journal cs1">Shaw RW (June 1988). "GnRH agonists-antagonists--clinical applications". <i>Eur. J. Obstet. Gynecol. Reprod. Biol</i>. <b>28</b> (2): 109–16. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0028-2243%2888%2990086-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0028-2243%2888%2990086-X'" tppabs="https://doi.org/10.1016%2F0028-2243%2888%2990086-X" class="external text external">10.1016/0028-2243(88)90086-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2969835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2969835'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2969835" class="external text external">2969835</a>.</cite></span></li><li id="cite_note-LemkeWilliams2012-20"> <span id="mw-reference-text-cite_note-LemkeWilliams2012-20" class="mw-reference-text"><cite id="CITEREFThomas_L._LemkeDavid_A._Williams2012" class="citation book cs1">Thomas L. Lemke; David A. Williams (24 January 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA230  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA230'" tppabs="https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA230" class="external text external"><i>Foye's Principles of Medicinal Chemistry</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>230–. ISBN<span>&nbsp;</span><bdi>978-1-60913-345-0</bdi>.</cite></span></li><li id="cite_note-FalconeHurd2017-21"> <span id="mw-reference-text-cite_note-FalconeHurd2017-21" class="mw-reference-text"><cite id="CITEREFTommaso_FalconeWilliam_W._Hurd2017" class="citation book cs1">Tommaso Falcone; William W. Hurd (14 June 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=pzgoDwAAQBAJ&pg=PA9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=pzgoDwAAQBAJ&pg=PA9'" tppabs="https://books.google.com/books?id=pzgoDwAAQBAJ&pg=PA9" class="external text external"><i>Clinical Reproductive Medicine and Surgery: A Practical Guide</i></a>. Springer. pp.<span>&nbsp;</span>9–. ISBN<span>&nbsp;</span><bdi>978-3-319-52210-4</bdi>.</cite></span></li><li id="cite_note-MunarrizTraish2009-22"> <span id="mw-reference-text-cite_note-MunarrizTraish2009-22" class="mw-reference-text"><cite id="CITEREFMunarrizTraish2009" class="citation journal cs1">Munarriz, Ricardo; Traish, Abdul (2009). "Impact of Androgen Deprivation on Male Sexual Function": 163–175. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2F978-1-60327-555-2_11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2F978-1-60327-555-2_11'" tppabs="https://doi.org/10.1007%2F978-1-60327-555-2_11" class="external text external">10.1007/978-1-60327-555-2_11</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text">DailyMed: <a href="javascript:if(confirm('http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6'" tppabs="http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6" class="external text external">Synarel – nafarelin acetate spray</a></span></li><li id="cite_note-pmid8569395-24"> <span id="mw-reference-text-cite_note-pmid8569395-24" class="mw-reference-text"><cite id="CITEREFHataHataKawamura1996" class="citation journal cs1">Hata T, Hata K, Kawamura T (February 1996). "Severe hyperkalaemia with nafarelin". <i>Lancet</i>. <b>347</b> (8997): 333. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2896%2990514-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2896%2990514-0'" tppabs="https://doi.org/10.1016%2FS0140-6736%2896%2990514-0" class="external text external">10.1016/S0140-6736(96)90514-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8569395  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8569395'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8569395" class="external text external">8569395</a>.</cite></span></li><li id="cite_note-pmid8477775-25"> <span id="mw-reference-text-cite_note-pmid8477775-25" class="mw-reference-text"><cite id="CITEREFKreuserKlingmüllerThiel1993" class="citation journal cs1">Kreuser ED, Klingmüller D, Thiel E (1993). "The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation". <i>Eur. Urol</i>. <b>23</b> (1): 157–63, discussion 163–4. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000474586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000474586'" tppabs="https://doi.org/10.1159%2F000474586" class="external text external">10.1159/000474586</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8477775  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8477775'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8477775" class="external text external">8477775</a>.</cite></span></li><li id="cite_note-Elks2014-26"> <span id="mw-reference-text-cite_note-Elks2014-26" class="mw-reference-text"><cite id="CITEREFJ._Elks2014" class="citation book cs1">J. Elks (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA846  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA846'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA846" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>846–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-MortonHall2012-27"> <span id="mw-reference-text-cite_note-MortonHall2012-27" class="mw-reference-text"><cite id="CITEREFI.K._MortonJudith_M._Hall2012" class="citation book cs1">I.K. Morton; Judith M. Hall (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189'" tppabs="https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA189" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>189–. ISBN<span>&nbsp;</span><bdi>978-94-011-4439-1</bdi>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFBarbieri1990" class="citation journal cs1">Barbieri RL (February 1990). "Comparison of the pharmacology of nafarelin and danazol". <i>Am. J. Obstet. Gynecol</i>. <b>162</b> (2): 581–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-9378%2890%2990436-B  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-9378%2890%2990436-B'" tppabs="https://doi.org/10.1016%2F0002-9378%2890%2990436-B" class="external text external">10.1016/0002-9378(90)90436-B</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2137975  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2137975'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2137975" class="external text external">2137975</a>.</cite></li>
<li><cite class="citation journal cs1">Chrisp P, Goa KL (April 1990). "Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions". <i>Drugs</i>. <b>39</b> (4): 523–51. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199039040-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199039040-00005'" tppabs="https://doi.org/10.2165%2F00003495-199039040-00005" class="external text external">10.2165/00003495-199039040-00005</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2140979  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2140979'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2140979" class="external text external">2140979</a>.</cite></li>
<li><cite id="CITEREFBurry1992" class="citation journal cs1">Burry KA (February 1992). "Nafarelin in the management of endometriosis: quality of life assessment". <i>Am. J. Obstet. Gynecol</i>. <b>166</b> (2): 735–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0002-9378%2892%2991705-F  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0002-9378%2892%2991705-F'" tppabs="https://doi.org/10.1016%2F0002-9378%2892%2991705-F" class="external text external">10.1016/0002-9378(92)91705-F</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1531576  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1531576'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1531576" class="external text external">1531576</a>.</cite></li>
<li><cite class="citation journal cs1">Minaguchi H, Wong JM, Snabes MC (June 2000). "Clinical use of nafarelin in the treatment of leiomyomas. A review of the literature". <i>J Reprod Med</i>. <b>45</b> (6): 481–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10900582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10900582'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10900582" class="external text external">10900582</a>.</cite></li></ul>
<p>
<br></p>
<div role="navigation" class="navbox" aria-labelledby="GnRH_and_gonadotropins" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GnRH_and_gonadotropins" style="font-size:114%;margin:0 4em"><a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr></a> and gonadotropins</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GnRH</abbr> modulators<br>(incl. analogues)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Peptide:</i> Azagly-nafarelin</li>
<li>Buserelin</li>
<li>Deslorelin</li>
<li>Fertirelin</li>
<li>Gonadorelin</li>
<li><a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">Goserelin</a></li>
<li>Histrelin</li>
<li>Lecirelin</li>
<li><a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">Leuprorelin (leuprolide)</a></li>
<li><a href="Nafarelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafarelin" title="Nafarelin">Nafarelin</a></li>
<li>Peforelin</li>
<li>Triptorelin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:9em;;text-align:center;">Antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Peptide:</i> <a href="Abarelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Abarelix" title="Abarelix">Abarelix</a></li>
<li><a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">Cetrorelix</a></li>
<li>Degarelix</li>
<li>Ganirelix</li></ul>

<ul><li><i>Non-peptide:</i> Elagolix</li>
<li>Linzagolix<sup>†</sup></li>
<li>Relugolix<sup>†</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Gonadotropins</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Preparations" scope="row" class="navbox-group" style="width:9em;;text-align:center;">Preparations</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Follicle-stimulating hormone</li>
<li><a href="Human_chorionic_gonadotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin">Human chorionic gonadotropin</a></li>
<li><a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">Luteinizing hormone</a></li>
<li><a href="Menotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Menotropin" title="Menotropin">Menotropin</a></li>
<li><a href="Urofollitropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Urofollitropin" title="Urofollitropin">Urofollitropin</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Others<br>(indirect)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;">Progonadotropins</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Sex steroid antagonists (via disinhibition of the <abbr>HPG</abbr> axis):</i> Antiandrogens (e.g., <a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">flutamide</a>, <a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">bicalutamide</a>, enzalutamide)</li>
<li>Antiestrogens/<abbr>SERMs</abbr> (e.g., <a href="Tamoxifen.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamoxifen" title="Tamoxifen">tamoxifen</a>, <a href="Clomifene.htm" tppabs="https://ptable.com/wiki/compounds/A/Clomifene" title="Clomifene">clomifene</a>, enclomifene)</li>
<li>Aromatase inhibitors (e.g., <a href="Anastrozole.htm" tppabs="https://ptable.com/wiki/compounds/A/Anastrozole" title="Anastrozole">anastrozole</a>)</li>
<li><abbr>GnRH</abbr> agonists (e.g., <a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone"><abbr>GnRH</abbr></a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;">Antigonadotropins</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Sex steroid agonists (via negative feedback on the <abbr>HPG</abbr> axis):</i> Androgens/anabolic steroids (e.g., testosterone, nandrolone esters, <a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">oxandrolone</a>)</li>
<li>D<sub>2</sub> receptor antagonists (prolactin releasers) (incl., <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a>, <a href="Metoclopramide.htm" tppabs="https://ptable.com/wiki/compounds/A/Metoclopramide" title="Metoclopramide">metoclopramide</a>, <a href="Risperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Risperidone" title="Risperidone">risperidone</a>, <a href="Haloperidol.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloperidol" title="Haloperidol">haloperidol</a>, <a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">chlorpromazine</a>, <a href="Sulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulpiride" title="Sulpiride">sulpiride</a>)</li>
<li>Estrogens (incl., bifluranol, estradiol, estradiol esters, ethinylestradiol, <a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">diethylstilbestrol</a>, paroxypropione)</li>
<li>Progestogens (incl. progestins, e.g., chlormadinone acetate, cyproterone acetate, hydroxyprogesterone caproate, gestonorone caproate, <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a>, megestrol acetate)</li></ul>

<ul><li><i>Others (mixed or unknown mechanism of action):</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li>Metallibure</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd><abbr>GnRH</abbr> and gonadotropin receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>Progestogens and antiprogestogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="GnRH_and_gonadotropin_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="GnRH_and_gonadotropin_receptor_modulators" style="font-size:114%;margin:0 4em"><abbr>GnRH</abbr> and gonadotropin receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GnRH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptides:</i> <span class="new">Alarelin</span></li>
<li><span class="new">Avorelin</span></li>
<li>Azagly-nafarelin</li>
<li>Buserelin</li>
<li>Deslorelin</li>
<li>Fertirelin</li>
<li><a href="Gonadotropin-releasing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gonadotropin-releasing_hormone" title="Gonadotropin-releasing hormone">GnRH</a></li>
<li>Gonadorelin</li>
<li><a href="Goserelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Goserelin" title="Goserelin">Goserelin</a></li>
<li>Histrelin</li>
<li><a href="Leuprorelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Leuprorelin" title="Leuprorelin">Leuprorelin (leuprolide)</a></li>
<li><span class="new">Lutrelin</span></li>
<li><a href="Nafarelin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafarelin" title="Nafarelin">Nafarelin</a></li>
<li>Peforelin</li>
<li><span class="new">Salmon GnRH</span></li>
<li>Triptorelin</li>
<li><span class="new">Zoptarelin</span></li>
<li>Zoptarelin doxorubicin</li></ul>

<ul><li><i>Antagonists:</i> <i>Peptides:</i> <a href="Abarelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Abarelix" title="Abarelix">Abarelix</a></li>
<li>Acyline</li>
<li><span class="new">Azaline B</span></li>
<li><a href="Cetrorelix.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetrorelix" title="Cetrorelix">Cetrorelix</a></li>
<li>Degarelix</li>
<li><span class="new">Detirelix</span></li>
<li>Ganirelix</li>
<li><span class="new">Iturelix (antide)</span></li>
<li><span class="new">LXT-101</span></li>
<li><span class="new">Ornirelix (ornitide)</span></li>
<li>Ozarelix</li>
<li><span class="new">Prazarelix</span></li>
<li><span class="new">Ramorelix</span></li>
<li><span class="new">Teverelix (antarelix)</span>; <i>Non-peptides:</i> Elagolix</li>
<li>Linzagolix</li>
<li>Opigolix</li>
<li>Relugolix</li>
<li>Sufugolix</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Gonadotropin</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>LH/hCG</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptides:</i> Choriogonadotropin alfa</li>
<li><a href="Human_chorionic_gonadotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_chorionic_gonadotropin" title="Human chorionic gonadotropin">Human chorionic gonadotropin</a></li>
<li><a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">Luteinizing hormone</a></li>
<li>Lutropin alfa</li>
<li><a href="Menotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Menotropin" title="Menotropin">Menotropin (human menopausal gonadotropin)</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>FSH</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <i>Peptides:</i> Corifollitropin alfa</li>
<li>Follicle-stimulating hormone</li>
<li>Follitropin alfa</li>
<li>Follitropin beta</li>
<li><span class="new">Follitropin epsilon</span></li>
<li><a href="Menotropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Menotropin" title="Menotropin">Menotropin (human menopausal gonadotropin)</a></li>
<li><a href="Urofollitropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Urofollitropin" title="Urofollitropin">Urofollitropin</a></li>
<li><span class="new">Varfollitropin alfa</span></li></ul>

<ul><li><i><abbr>NAMs</abbr>:</i> <i>Non-peptides:</i> <span class="new">ADX-61623</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><i><b>See also:</b> Receptor/signaling modulators • Signaling peptide/protein receptor modulators • GnRH and gonadotropins</i></li></ul>
</div></td></tr></tbody></table></div><span>
</span>




<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-19" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Nafarelin&oldid=963442696  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Nafarelin&oldid=963442696'" tppabs="https://en.wikipedia.org/wiki/?title=Nafarelin&oldid=963442696">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>